Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk

We investigated whether serial measurements of circulating tumor DNA (ctDNA) and functional tumor volume (FTV) by magnetic resonance imaging (MRI) can be combined to improve prediction of pathologic complete response (pCR) and estimation of recurrence risk in early breast cancer patients treated wit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:NPJ Breast Cancer
Autors principals: Magbanua, Mark Jesus M., Li, Wen, Wolf, Denise M., Yau, Christina, Hirst, Gillian L., Swigart, Lamorna Brown, Newitt, David C., Gibbs, Jessica, Delson, Amy L., Kalashnikova, Ekaterina, Aleshin, Alexey, Zimmermann, Bernhard, Chien, A. Jo, Tripathy, Debu, Esserman, Laura, Hylton, Nola, van ‘t Veer, Laura
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7994408/
https://ncbi.nlm.nih.gov/pubmed/33767190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-021-00239-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars